BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #546Biotechnology
$34.87 −$0.81 (-2.26%)
Market open · Oct 1, 1:10 pm ET · After hours $35.36 -0.88%
Open$35.28
Prev close$35.68
Day range$34.63 – $35.80
Volume3.59M
Market cap$21.76B
P/E (TTM)27.6
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$40.00+14.7% vs. price
  • Buy 89%
  • Hold 11%
Low $35.00Now $34.87Avg $40.00High $43.00

Recent rating changes

The last 20 actions on file set price targets from $32.00 to $43.00, averaging $39.18.

DateFirmRatingTarget
14 Sep 2026 H.C. Wainwright BUY $40.00
12 Aug 2026 Truist Financial BUY –
11 Aug 2026 William Blair BUY –
7 Aug 2026 TD Cowen BUY $43.00
7 Aug 2026 BofA Securities BUY –
7 Aug 2026 Truist Financial BUY $40.00
7 Aug 2026 Morgan Stanley HOLD $35.00
7 Aug 2026 Jefferies BUY –
7 Aug 2026 Barclays BUY –
6 Aug 2026 TD Cowen BUY $43.00
6 Aug 2026 William Blair BUY –
6 Aug 2026 Guggenheim BUY $42.00
31 Jul 2026 Truist Financial BUY –
23 Jul 2026 Morgan Stanley HOLD $33.00
22 Jul 2026 TD Cowen BUY $43.00
14 Jul 2026 William Blair BUY –
13 Jul 2026 TD Cowen HOLD $32.00
13 Jul 2026 H.C. Wainwright BUY $40.00
2 Jul 2026 H.C. Wainwright BUY $40.00
30 Jun 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on GMAB.

Leave a comment

Scroll to Top